Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Medicare

Republican seeking to raise Social Security age claims ‘people want to work longer’

The Georgia Republican says, ‘people come up to me, they actually want to work longer’

The Independent UK

More states are doing what they can to cap insulin costs

In her early 20s, Karisa Hunt learned the hard lesson of what happens when someone rations life-preserving medication.

Tribune News Service

McCarthy may be speaker, but Trump is the real leader of House Republicans

After Trump’s pick for speaker narrowly won, what sway will the former president hold over Congress’s Republican majority?

The Guardian - US

From analysis to the latest developments in health,
read the most diverse news in one place.

Jackie Calmes: Republicans being the party of fiscal conservatism? Don't believe it for a minute

With a Democrat inhabiting the White House, perhaps the most predictable thing about House Republicans' return to power is this: They've rediscovered their faux fiscal conservatism.

Los Angeles Times

UnitedHealth sees quarterly earnings increase 17% to $4.9B

UnitedHealth Group saw profits leap 17% to $4.9 billion during the fourth quarter, beating analyst estimates and prompting the company to reiterate its upbeat financial guidance for the new year.

Tribune News Service

Debt limit battle set to dominate 2023 fiscal agenda

WASHINGTON — Lifting the statutory debt ceiling is set to dominate this year’s budget agenda. Republicans first need to agree among themselves on what to ask for in exchange.

Tribune News Service

What the FDA's accelerated approval of a new Alzheimer's drug could mean for those with the disease – 5 questions answered about lecanemab

The U.S. Food and Drug Administration approved the medication lecanemab, sold under the brand name Leqembi, on Jan. 6, 2023, through an “accelerated approval pathway” that fast-tracks promising clinical treatments for diseases in which there are no other currently effective options.

The Conversation

Read news from The Economist, FT, and more,
with one subscription

LZ Granderson: Republicans want to cut Medicare. Here's how real leaders would handle the deficit

Our population was getting older and broker.

Los Angeles Times

Debt limit battle set to dominate 2023 fiscal agenda - Roll Call

Lifting the debt ceiling is set to dominate this year's budget agenda. Republicans first need to agree on what to ask for in exchange.

Roll Call

A new Alzheimer’s drug has been approved. What to know about lecanemab

A new drug that appears to slow early Alzheimer’s disease is coming to the market.

Tribune News Service

Unity is new tone for often-divided Democrats in Washington

Not so long ago, Democratic in-fighting doomed a sweeping social spending package despite the party controlling Congress

The Independent UK

Speaker McCarthy: That's no joke, folks

As usual, the mockery was a way to avoid the real emotions we should feel: How the hell did America get here?

Salon

CVS is exploring a $10 billion-plus acquisition of Oak Street Health

CVS Health Corp. is exploring an acquisition of Oak Street Health Inc., which runs primary care centers for Medicare recipients, according to people familiar with the matter.

Tribune News Service

Rep. Arrington gets Steering Committee nod for House Budget gavel - Roll Call

Texas GOP Rep. Jodey C. Arrington is poised to become the next House Budget chair, after the Republican Steering Committee recommended him.

Roll Call

Get all your
news in one place.

100's of premium titles.
One news app.

Tribune News Service

McCarthy concessions raise stakes on budget, debt limit

WASHINGTON — The deal between Speaker Kevin McCarthy and his conservative detractors lays a foundation for the massive spending cuts that some want, but also sets up a daunting challenge for GOP lawmakers who want to keep the government functioning after winning control of the House.

Roll Call

McCarthy concessions raise stakes on budget, debt limit - Roll Call

The House Republican deal lays a foundation for the spending cuts that some want, but also a challenge to keep the government functioning.

The Guardian - AU

Tinkering with Medicare funding won’t fix the mental health system. We must overhaul our approach to care

By simply giving more cash to selected programs, we deflect attention away from smart, system-wide reforms that would help those who need it most

Tribune News Service

‘Let’s fight now’ over debt ceiling, House GOP lawmaker says

WASHINGTON — A conservative Republican at the center of the tortured effort to elect House Speaker Kevin McCarthy says he’d welcome a hard-fought battle over the U.S. debt ceiling, but said both parties should start negotiating terms for the increase now so it doesn’t go down to the wire.

Get all your
news in one place.

100's of premium titles.
One news app.

Tribune News Service

‘Let’s fight now’ over debt ceiling, House GOP lawmaker says

The Canberra Times

New report shows how much more Canberrans pay to see a doctor

Canberra's bulk-billing rate is 40 per cent below the national average.

WEKU

FDA approves Alzheimer's drug that appears to modestly slow disease

An Alzheimer's drug that removes the substance amyloid from the brain has received a conditional approval from the FDA. A large study found the drug decreased the loss of thinking and memory by 27%.

ABC News

Gladstone community 'shocked' by closure of bulk-billed GP clinic Toolooa Family Practice

Gladstone residents are "shocked" by the sudden closure of their local GP practice but doctors warn it won't be the last, while calling on the federal government to take "urgent measures".

The Independent UK

Alzheimer’s drug that slows disease progression approved by FDA

U.S. health officials have approved a new Alzheimer’s drug that modestly slows the brain-robbing disease

The Independent UK

Alzheimer's drug that modestly slows disease OK'd by FDA

U.S. health officials have approved a new Alzheimer’s drug that modestly slows the brain-robbing disease

Axios

2023 could be a banner year for prescription drugs

There's a large pipeline of promising yet expensive drugs that could get approved.

1 … 131 132 133 134

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

House of Representatives

1,315 stories

Department of Justice

Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.